triazoles has been researched along with Blastomycosis in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (11.11) | 18.7374 |
1990's | 7 (25.93) | 18.2507 |
2000's | 8 (29.63) | 29.6817 |
2010's | 7 (25.93) | 24.3611 |
2020's | 2 (7.41) | 2.80 |
Authors | Studies |
---|---|
Kauffman, CA; Schwartz, IS | 1 |
Kaye, K; Majdick, K; Shorman, MA | 1 |
Hussaini, SMQ; Madut, D; Pavlisko, EN; Perfect, JR; Schell, WA; Thielman, NM; Tong, BC | 1 |
Akture, E; Baskaya, MK; Salamat, S | 1 |
Bush, JW; Del Bigio, MR; Embil, JM; Krawitz, S; McDonald, PJ; Wuerz, T | 1 |
Day, SR; Hazen, KC; Moore, CC; Weiss, DB | 1 |
Azie, N; Cornely, OA; Engelhardt, M; Kovanda, L; Lee, M; Maher, R; Ostrosky-Zeichner, L; Perfect, JR; Queiroz-Telles, F; Rendon, A; Ribeiro Dos Santos, R; Thompson, GR; Vazquez, JA | 1 |
Andes, D; Arnold, S; Baddour, LM; Blair, J; Freifeld, A; Lentnek, A; Proia, L; Spellberg, B; Wheat, LJ | 1 |
Sung, VW | 1 |
Almony, A; Apte, RS; Kraus, CL | 1 |
Flowers, SA; Rogers, PD; Ta, M | 1 |
Osmond, GW; Puri, PK; Walters, RW | 1 |
Harnisch, DO; Proia, LA | 1 |
Aksamit, AJ; Bakleh, M; Marshall, WF; Tleyjeh, IM | 1 |
Kamani, N; Panicker, J; Walsh, T | 1 |
Borgia, SM; El-Helou, P; Fuller, JD; Sarabia, A | 1 |
Brummer, E; Hanson, LH; Stevens, DA | 2 |
Picard, M; Sugar, AM | 1 |
Clemons, KV; Hanson, LH; Stevens, DA | 1 |
Liu, XP; Sugar, AM | 2 |
Noble, L; Picard, M; Sugar, AM | 1 |
Hector, RF; Pappagianis, D; Plempel, M; Theodoropoulos, G; Zimmer, BL | 1 |
Brummer, E; Hanson, LH; Stevens, DA; Tucker, RM | 1 |
Diamond, RD; Lyman, CA; Sugar, AM | 1 |
Brummer, E; Lefler, E; Perlman, AM; Stevens, DA | 1 |
3 review(s) available for triazoles and Blastomycosis
Article | Year |
---|---|
Blastomycosis.
Topics: Amphotericin B; Antifungal Agents; Blastomyces; Blastomycosis; Humans; Immunocompromised Host; Itraconazole; Triazoles; Voriconazole | 2020 |
Successful treatment of osseous blastomycosis without pulmonary or disseminated disease and review of the literature.
Topics: Antifungal Agents; Blastomyces; Blastomycosis; Bone Diseases; Humans; Male; Middle Aged; Treatment Outcome; Triazoles | 2014 |
The role of voriconazole in the treatment of central nervous system blastomycosis.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Blastomyces; Blastomycosis; Central Nervous System Fungal Infections; Child; Child, Preschool; Humans; Infant; Magnetic Resonance Imaging; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2009 |
1 trial(s) available for triazoles and Blastomycosis
Article | Year |
---|---|
Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses.
Topics: Adult; Aged; Antifungal Agents; Blastomycosis; Coccidioidomycosis; Cryptococcosis; Female; Histoplasmosis; Humans; Male; Middle Aged; Mycoses; Nitriles; Paracoccidioidomycosis; Pyridines; Triazoles; Young Adult | 2016 |
23 other study(ies) available for triazoles and Blastomycosis
Article | Year |
---|---|
Central nervous system blastomycosis clinical characteristics and outcomes.
Topics: Adult; Antifungal Agents; Azoles; Blastomyces; Blastomycosis; Central Nervous System Fungal Infections; Cohort Studies; Female; Humans; Male; Middle Aged; Tennessee; Treatment Outcome; Triazoles; Voriconazole | 2021 |
Pulmonary blastomycosis presenting as primary lung cancer.
Topics: Antifungal Agents; Blastomyces; Blastomycosis; Diagnosis, Differential; DNA, Fungal; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed; Triazoles | 2018 |
Intracranial blastomycosis presenting as an enhancing cerebellopontine mass.
Topics: Adult; Antifungal Agents; Blastomyces; Blastomycosis; Cerebellar Diseases; Cerebellar Neoplasms; Cerebellopontine Angle; Craniotomy; Humans; Immunoenzyme Techniques; Magnetic Resonance Imaging; Male; Necrosis; Positron-Emission Tomography; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
Outcomes of persons with blastomycosis involving the central nervous system.
Topics: Amphotericin B; Azoles; Biopsy; Blastomyces; Blastomycosis; Central Nervous System Fungal Infections; Humans; Magnetic Resonance Imaging; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Voriconazole use for endemic fungal infections.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Blastomycosis; Coccidioidomycosis; Female; Histoplasmosis; Humans; Male; Middle Aged; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2009 |
Blastomycosis.
Topics: Adult; Antifungal Agents; Blastomycosis; Contrast Media; Headache; Humans; Magnetic Resonance Imaging; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Successful treatment of choroidal blastomycosis with oral administration of voriconazole.
Topics: Administration, Oral; Antifungal Agents; Blastomycosis; Choroid Diseases; Dose-Response Relationship, Drug; Eye Infections, Fungal; Follow-Up Studies; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2009 |
Cutaneous alternariosis microscopically mimicking blastomycosis.
Topics: Alternaria; Alternariosis; Antifungal Agents; Blastomycosis; Combined Modality Therapy; Dermatologic Surgical Procedures; Diagnosis, Differential; Humans; Immunocompromised Host; Immunosuppressive Agents; Knee; Male; Middle Aged; Pyrimidines; Skin; Triazoles; Voriconazole | 2011 |
Successful use of posaconazole for treatment of blastomycosis.
Topics: Adult; Antifungal Agents; Blastomycosis; Female; Humans; Itraconazole; Male; Middle Aged; Triazoles | 2012 |
Successful treatment of cerebral blastomycosis with voriconazole.
Topics: Antifungal Agents; Blastomycosis; Brain Diseases; Female; Humans; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2005 |
Recurrent central nervous system blastomycosis in an immunocompetent child treated successfully with sequential liposomal amphotericin B and voriconazole.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Blastomyces; Blastomycosis; Central Nervous System Fungal Infections; Drug Administration Schedule; Humans; Immunocompetence; Male; Pyrimidines; Recurrence; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Cerebral blastomycosis: a case series incorporating voriconazole in the treatment regimen.
Topics: Adult; Antifungal Agents; Blastomycosis; Brain Diseases; Central Nervous System Fungal Infections; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2006 |
IL-4, IgE, and interferon-gamma production in pulmonary blastomycosis: comparison in mice untreated, immunized, or treated with an antifungal (SCH 39304).
Topics: Animals; Antifungal Agents; Antigens, Surface; Blastomycosis; Cells, Cultured; Disease Models, Animal; Immunization; Immunoglobulin E; Interferons; Interleukin-4; Lung; Lymph Nodes; Lymphocytes; Male; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Spleen; Thy-1 Antigens; Triazoles | 1993 |
Treatment of murine pulmonary blastomycosis with SCH 51048, a broad-spectrum triazole antifungal agent.
Topics: Animals; Antifungal Agents; Blastomycosis; Lung Diseases, Fungal; Male; Mice; Mice, Inbred ICR; Triazoles | 1995 |
Activities of the triazole D0870 in vitro and against murine blastomycosis.
Topics: Animals; Antifungal Agents; Blastomyces; Blastomycosis; Fluconazole; Male; Mice; Microbial Sensitivity Tests; Triazoles | 1993 |
In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis.
Topics: Amphotericin B; Animals; Antifungal Agents; Blastomyces; Blastomycosis; Drug Evaluation, Preclinical; Fluconazole; Lethal Dose 50; Lung Diseases, Fungal; Male; Mice; Microbial Sensitivity Tests; Triazoles | 1996 |
Efficacy of voriconazole in treatment of murine pulmonary blastomycosis.
Topics: Animals; Antifungal Agents; Blastomycosis; Colony Count, Microbial; Lung; Male; Mice; Mice, Inbred BALB C; Pyrimidines; Survival Analysis; Time Factors; Triazoles; Voriconazole | 2001 |
SCH 39304 in the treatment of acute or established murine pulmonary blastomycosis.
Topics: Animals; Antifungal Agents; Blastomycosis; Fluconazole; Ketoconazole; Lung Diseases; Mice; Mice, Inbred BALB C; Triazoles | 1991 |
Treatment of murine pulmonary blastomycosis with SCH 39304, a new triazole antifungal agent.
Topics: Amphotericin B; Animals; Antifungal Agents; Blastomycosis; Fluconazole; Lung; Lung Diseases, Fungal; Male; Mice; Mice, Inbred BALB C; Triazoles | 1990 |
Therapeutic effect of the triazole Bay R 3783 in mouse models of coccidioidomycosis, blastomycosis, and histoplasmosis.
Topics: Animals; Antifungal Agents; Biological Assay; Blastomycosis; Coccidioidomycosis; Disease Models, Animal; Female; Histoplasmosis; Mice; Microbial Sensitivity Tests; Survival Rate; Triazoles | 1990 |
Activity of ICI 195,739, a new oral triazole, compared with that of ketoconazole in the therapy of experimental murine blastomycosis.
Topics: Animals; Antifungal Agents; Blastomyces; Blastomycosis; Ketoconazole; Male; Mice; Mice, Inbred BALB C; Time Factors; Triazoles | 1989 |
Comparative activities of UK-49,858 and amphotericin B against Blastomyces dermatitidis infections in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Blastomycosis; Fluconazole; Male; Mice; Mice, Inbred BALB C; Triazoles | 1986 |
Activities of the modified polyene N-D-ornithyl amphotericin methyl ester and the azoles ICI 153066, Bay n 7133, and Bay l 9139 compared with those of amphotericin B and ketoconazole in the therapy of experimental blastomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Blastomycosis; Imidazoles; Ketoconazole; Male; Mice; Mice, Inbred BALB C; Time Factors; Triazoles | 1985 |